These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23664937)

  • 1. Effects of β-cyclodextrin on the intestinal absorption of berberine hydrochloride, a P-glycoprotein substrate.
    Zhang Y; Cui YL; Gao LN; Jiang HL
    Int J Biol Macromol; 2013 Aug; 59():363-71. PubMed ID: 23664937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing effect of hydroxypropyl-β-cyclodextrin on the intestinal absorption process of genipin.
    Zhang Y; Meng FC; Cui YL; Song YF
    J Agric Food Chem; 2011 Oct; 59(20):10919-26. PubMed ID: 21910453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the intestinal absorption mechanism of icariin in the nanocavities of cyclodextrins.
    Zhang Y; Wang QS; Cui YL; Meng FC; Lin KM
    Int J Nanomedicine; 2012; 7():4239-49. PubMed ID: 22904630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexation of tanshinone IIA with 2-hydroxypropyl-beta-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats.
    Wang L; Jiang X; Xu W; Li C
    Int J Pharm; 2007 Aug; 341(1-2):58-67. PubMed ID: 17482783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
    Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS; Vavia PR
    Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
    Chauhan R; Madan J; Kaushik D; Sardana S; Pandey RS; Sharma R
    Pharm Dev Technol; 2013; 18(2):313-22. PubMed ID: 21699389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Ranpise NS; Kulkarni NS; Mair PD; Ranade AN
    Pharm Dev Technol; 2010; 15(1):64-70. PubMed ID: 19505225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
    Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
    Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced aqueous solubility and bioavailability of capsaicin by the preparation of an inclusion complex.
    Chen X; Sun X; Ren K; Zhang X; Zhang Z; Gong T
    Arzneimittelforschung; 2010; 60(9):571-4. PubMed ID: 21117501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-state characterization of sertraline base-β-cyclodextrin inclusion complex.
    Ogawa N; Hashimoto T; Furuishi T; Nagase H; Endo T; Yamamoto H; Kawashima Y; Ueda H
    J Pharm Biomed Anal; 2015 Mar; 107():265-72. PubMed ID: 25637819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.
    Hu L; Zhang H; Song W; Gu D; Hu Q
    Carbohydr Polym; 2012 Nov; 90(4):1719-24. PubMed ID: 22944438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
    Patil AL; Pore YV; Kuchekar BS; Late SG
    Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug product development and pharmacological evaluation of a sparingly soluble novel camptothecin analog for peroral administration.
    Nekkanti V; Karatgi P; Paruchuri S; Pillai R
    Drug Deliv; 2011 May; 18(4):294-303. PubMed ID: 21214430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of berberine.
    Xiong W; Sang W; Linghu KG; Zhong ZF; Cheang WS; Li J; Hu YJ; Yu H; Wang YT
    Int J Nanomedicine; 2018; 13():3781-3793. PubMed ID: 29988733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preparation and stuctural behavior of the inclusion complex of beta-cyclodextrin and coptisine hydrochloride].
    Chen HY; Jin Z; Chen SQ
    Zhong Yao Cai; 2012 Jan; 35(1):138-41. PubMed ID: 22734425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
    Sinha VR; Nanda A; Chadha R; Goel H
    Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.
    Sbârcea L; Udrescu L; Drăgan L; Trandafirescu C; Szabadai Z; Bojiţă M
    Pharmazie; 2011 Aug; 66(8):584-9. PubMed ID: 21901980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.